The Delaware jury found Hunter Biden, son of the current President of the United States, guilty on Tuesday. He was accused of three serious charges, one of them weapons possession.

“Jurors found Hunter Biden guilty of lying to a federally licensed gun dealer, making a false statement on the application that he did not use drugs, and illegally possessing the gun for 11 days.”

Once the verdict was read, it was learned that Hunter Biden faces a sentence of 25 years in prison when he is sentenced by Judge Maryellen Noreika. However, it is necessary to clarify that in the case of first-time offenders, they usually do not reach the maximum sentence.

Joe Biden, President of the nation, indicated that he would abide by the jury’s decision and indicated in a statement: “Jill and I will always be there for Hunter and the rest of our family with our love and support. “Nothing will ever change that.”

M.Pino

Source: vozdeamerica

(Reference image source: @CNNEE, X)

Visit our news channel on Google News and follow us to get accurate, interesting information and stay up to date with everything. You can also see our daily content on Twitter and Instagram

La entrada Hunter Biden found guilty of three serious charges apareció primero en Bitfinance.

They will market the Oravax vaccine in Latin America. The companies Genomma Lab from Mexico and Oramed, an Israeli pharmaceutical company, signed a commercial alliance that will allow them to carry out the necessary tests to sell the oral vaccine against the Covid-19 virus in Mexico. And later they will be extended to all the southern countries of the continent.

Oravax is an oral vaccine that was developed with “three specific proteins that resemble components of the SARS CoV-2 virus, including some proteins that are less susceptible to mutation”. That is why it is considered potentially very effective in protecting against the different variants and future mutations of this virus, which has kept the world practically paralyzed for two years and which once again has Europe as its epicenter.

The commercialization of this vaccine in Latin America would be of great benefit for the prevention of Covid-19 in an expeditious and comfortable way, because it does not require a cold chain for its conservation, nor health centers or special spaces that have been called vaccination centers, since it is only a pill that can be ingested anywhere or at home with a glass of water.

Oral administration of the vaccine could give greater results and safety by minimizing possible side effects. The development of an oral vaccine allows us to envision a future without pandemic and a “return to our normal lives.”

Vulnerable communities will be favored

With the commercialization of the vaccine, many vulnerable communities or populations will benefit mainly due to the logistical difficulties that some states present in accessing remote communities. Rodrigo Herrera, president of the Board of Genomma Lab, indicated: “A vaccine in the form of a pill would allow reaching the most isolated and vulnerable communities quickly and effectively.”

He highlighted the effort that some governments have made to buy vaccines, but distribution in their respective regions and communities has generated a series of major difficulties, limiting the fulfillment of the objectives in the vaccination of the entire population.

M. Rodríguez

Source: elnacional.com and other news media

La entrada They will commercialize the Oravax vaccine in Latin America apareció primero en Bitfinance.

The UK Medicines and Health Products Regulatory Agency (MRHA) authorized the use of Lagevrio (Molnupiravir), an oral antiviral developed by the US laboratory Merck, which could become a crucial tool in the fight against Covid-19.

The MRHA, a scientific, autonomous and independent advisory body of the government, highlighted that the “rigorous and meticulous investigation process of safety, quality and effectiveness” determined that the “antiviral is safe and effective”. It is considered by the Commission of Human Medicines as the first antiviral medicine to be used in the treatment of Covid-19.

The regulatory agency explained that Lagevrio’s process of action consists of interfering in the replication of the virus, preventing it from duplicating, controlling it the body and minimizing the danger of the disease.

According to clinical tests, Lagevrio is more effective when ingested in the early stages of the disease, which is why it is recommended to apply it immediately after obtaining confirmation of the virus in the body or five days after presenting symptoms.

The United Kingdom has become the first country in the world to approve the use of an oral medicine to confront this terrible virus that has claimed the lives of many citizens globally. UK Health and Social Care Secretary Sajid Javid called it a “historic day” for the country.

He also highlighted the importance of having a drug that can be “taken at home”, which – in his opinion – will change “the game for the most vulnerable and immunosuppressed, who will soon be able to receive innovative treatment.”

M. Rodríguez

Source: finazasdigital

La entrada United Kingdom approved first oral antiviral against Covid-19 apareció primero en Bitfinance.

The Internet giant will apply, starting in September, a new pilot program that will aim to contain violations of its advertising policies, particularly for recidivist advertisers. Its new system will consist of sending warnings to advertisers who violate its regulations. After three strikes, the company could completely remove the ads.

According to the statement, Google “will issue a first warning and after that up to three strikes for each violation of our policies on dishonest behavior, unapproved substances and dangerous products or services, this policy includes advertisements that promote misleading behavior or products, such as the creation of false documents, piracy services and even spyware, as well as those that are directed to products such as tobacco, drugs or weapons, among other types of content”.

For some years these prohibitions have been active in Google Adsense, but with this new program the system will sanction, in a more decisive way, those who violate them.

One, two, three… out!

The Google Adsense penalty system will first send a warning without penalties to the advertiser and remove the ad that violates the rules.

If the advertiser repeats the breach of the policies, in a period of 90 days, Google Adsense will send the first strike, which contains the temporary suspension of the account for 3 days, during which the ads will not be eligible to be published.

The second strike will be applied to those who repeat a violation of the same policy for which they received the first warning within 90 days. The account will be suspended for 7 days and your ads will not be published.

And the third strike will be granted to those who violate the same policy for which they received the second warning within 90 days after the previous strike. Thus, the account will be definitively suspended.

The company will be very clear with its warnings and each time a strike is issued, the advertiser will receive an email informing them of the violation. Additionally, Google affirms that its advertisers will have the right to appeal any decision regarding non-compliance with its policies.

M. Rodríguez

Source: marketing4ecommerce

La entrada Google will apply new measures to advertisers who violate its policies apareció primero en Bitfinance.